Lo JC, O'Ryan FS, Gordon NP, Yang J, Hui RL, Martin D, Hutchinson M, Lathon PV, Sanchez G, Silver P, Chandra M, McCloskey CA, Staffa JA, Willy M, Selby JV, Go AS (2010) Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg 68(2):243–253. https://doi.org/10.1016/j.joms.2009.03.050
Article
PubMed
Google Scholar
Beth-Tasdogan NH, Mayer B, Hussein H, Zolk O (2017) Interventions for managing medication-related osteonecrosis of the jaw. Cochrane Database Syst Rev 10:CD012432. https://doi.org/10.1002/14651858
Article
PubMed
Google Scholar
Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61(9):1115–1117. https://doi.org/10.1016/S0278-2391(03)00720-1
Article
Google Scholar
Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O'Ryan F (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw-2014 update. J Oral Maxillofac Surg 72(10):1938–1956. https://doi.org/10.1016/j.joms.2014.04.031
Article
Google Scholar
Ikebe T (2013) Pathophysiology of BRONJ: Drug-related osteoclastic disease of the jaw. Oral Sci Int 10(1):1–8. https://doi.org/10.1016/S1348-8643(12)00045-6
Article
Google Scholar
Nancollas GH, Tang R, Phipps RJ, Henneman Z, Gulde S, Wu W, Mangood A, Russell RGG, Ebetino FH (2006) Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. Bone 38(5):617–627. https://doi.org/10.1016/j.bone.2005.05.003
Article
PubMed
Google Scholar
Urade M, Tanaka N, Furusawa K, Shimada J, Shibata T, Kirita T, Yamamoto T, Ikebe T, Kitagawa Y, Fukuta J (2011) Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan. J Oral Maxillofac Surg 69(11):e364–e371. https://doi.org/10.1016/j.joms.2011.03.051
Article
PubMed
Google Scholar
Sparabombe S, Vitali L, Nori A, Berlin RS, Mazur M, Orsini G et al (2014) Risk assessment of BRONJ in oncologic patients treated with bisphosphonates: follow-up to 18 months. Int J Dent 2014:475859
Article
Google Scholar
Fliefel R, Troltzsch M, Kuhnisch J, Ehrenfeld M, Otto S (2015) Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review. Int J Oral Maxillofac Surg 44(5):568–585. https://doi.org/10.1016/j.ijom.2015.01.026
Article
PubMed
Google Scholar
Otto S, Schreyer C, Hafner S, Mast G, Ehrenfeld M, Sturzenbaum S et al (2012) Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment. J Craniomaxillofac Surg 40(4):303–309. https://doi.org/10.1016/j.jcms.2011.05.003
Article
PubMed
Google Scholar
Marx RE, Cillo JE Jr, Ulloa JJ (2007) Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 65(12):2397–2410. https://doi.org/10.1016/j.joms.2007.08.003
Article
PubMed
Google Scholar
Anavi-Lev K, Anavi Y, Chaushu G, Alon DM, Gal G, Kaplan I (2013) Bisphosphonate related osteonecrosis of the jaws: clinico-pathological investigation and histomorphometric analysis. Oral Surg Oral Med Oral Pathol Oral Radiol 115(5):660–666. https://doi.org/10.1016/j.oooo.2013.03.001
Article
PubMed
Google Scholar
Nisi M, Karapetsa D, Gennai S, Ramaglia L, Graziani F, Gabriele M (2018) Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up. J Craniomaxillofac Surg 46(7):1153–1158. https://doi.org/10.1016/j.jcms.2018.05.003
Article
PubMed
Google Scholar
Carlson ER, Basile JD (2009) The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 67(5):85–95. https://doi.org/10.1016/j.joms.2009.01.006
Article
PubMed
Google Scholar
Shintani T, Hayashido Y, Mukasa H, Akagi E, Hoshino M, Ishida Y, Hamana T, Okamoto K, Kanda T, Koizumi K, Yoshioka Y, Tani R, Toratani S, Okamoto T (2015) Comparison of the prognosis of bisphosphonate-related osteonecrosis of the jaw caused by oral and intravenous bisphosphonates. Int J Oral Maxillofac Surg 44(7):840–844. https://doi.org/10.1016/j.ijom.2015.03.013
Article
PubMed
Google Scholar
Hallmer F, Bjornland T, Nicklasson A, Becktor JP, Andersson G (2014) Osteonecrosis of the jaw in patients treated with oral and intravenous bisphosphonates: experience in Sweden. Oral Surg Oral Med Oral Pathol Oral Radiol 118(2):202–208. https://doi.org/10.1016/j.oooo.2014.05.006
Article
PubMed
Google Scholar
Bermudez-Bejarano EB, Serrera-Figallo MA, Gutierrez-Corrales A, Romero-Ruiz MM, Castillo-de-Oyague R, Gutierrez-Perez JL et al (2017) Analysis of different therapeutic protocols for osteonecrosis of the jaw associated with oral and intravenous bisphosphonates. Med Oral Patol Oral Cir Bucal 22:e43–e57
PubMed
Google Scholar
Rocha GC, Jaguar GC, Moreira CR, Neves EG, Fonseca FP, Pedreira EN (2012) Radiographic evaluation of maxillofacial region in oncology patients treated with bisphosphonates. Oral Surg Oral Med Oral Pathol Oral Radiol 114(5):S19–S25. https://doi.org/10.1016/j.tripleo.2011.08.016
Article
PubMed
Google Scholar
Choi SY, An CH, Kim SY, Kwon TG (2013) Bone turnover and inflammatory markers of bisphosphonate-related osteonecrosis of the jaw in female osteoporosis patients. J Oral Maxillofac Surg, Med, Pathol 25(2):123–128. https://doi.org/10.1016/j.ajoms.2012.06.007
Article
Google Scholar
Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O'Ryan F et al (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30(1):3–23. https://doi.org/10.1002/jbmr.2405
Article
PubMed
Google Scholar
Baim S, Miller PD (2009) Assessing the clinical utility of serum CTX in postmenopausal osteoporosis and its use in predicting risk of osteonecrosis of the jaw. J Bone Miner Res 24(4):561–574. https://doi.org/10.1359/jbmr.090203
Article
PubMed
Google Scholar
Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S, McCauley L, McGowan J, McKee M, Mohla S, Pendrys DG, Raisz LG, Ruggiero SL, Shafer DM, Shum L, Silverman SL, van Poznak C, Watts N, Woo SB, Shane E, American Society for Bone and Mineral Research (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22(10):1479–1491. https://doi.org/10.1359/jbmr.0707onj
Article
PubMed
Google Scholar
Thomas C, Spanidis M, Engel C, Roos FC, Frees S, Neisius A, Hampel C, Rubenwolf P, Thüroff JW, Walter C, Miederer M (2016) Bone scintigraphy predicts bisphosphonate-induced osteonecrosis of the jaw (BRONJ) in patients with metastatic castration-resistant prostate cancer (mCRPC). Clin Oral Investig 20(4):753–758. https://doi.org/10.1007/s00784-015-1563-8
Article
PubMed
Google Scholar
Sedghizadeh PP, Stanley K, Caligiuri M, Hofkes S, Lowry B, Shuler CF (2009) Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry. J Am Dent Assoc 140(1):61–66. https://doi.org/10.14219/jada.archive.2009.0019
Article
PubMed
Google Scholar
Shibahara T, Morikawa T, Yago K, Kishimoto H, Imai Y, Kurita K (2018) National Survey on Bisphosphonate-Related Osteonecrosis of the Jaws in Japan. J Oral Maxillofac Surg 76(10):2105–2112. https://doi.org/10.1016/j.joms.2018.04.009
Article
PubMed
Google Scholar
Lin TC, Yang CY, Kao Yang YH, Lin SJ (2014) Incidence and risk of osteonecrosis of the jaw among the Taiwan osteoporosis population. Osteoporos Int 25(5):1503–1511. https://doi.org/10.1007/s00198-014-2624-6
Article
PubMed
Google Scholar
Ulmner M, Jarnbring F, Torring O (2014) Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate. J Oral Maxillofac Surg 72(1):76–82. https://doi.org/10.1016/j.joms.2013.06.221
Article
PubMed
Google Scholar
Kim SH, Lee YK, Kim TY, Ha YC, Jang S, Kim HY (2021) Incidence of and risk for osteonecrosis of the jaw in Korean osteoporosis patients treated with bisphosphonates: A nationwide cohort-study. Bone 143:115650. https://doi.org/10.1016/j.bone.2020.115650
Article
PubMed
Google Scholar
Grewal VS, Fayans EP (2008) Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management. Todays FDA 20(38-41):43–36
Google Scholar
Lee JK, Kim KW, Choi JY, Moon SY, Kim SG, Kim CH, Kim HM, Kwon YD, Kim YD, Lee DK, Min SK, Park IS, Park YW, Kook MS, Park HJ, Baek JA, Park JW, Kwon TG (2013) Bisphosphonates-related osteonecrosis of the jaw in Korea: a preliminary report. J Korean Assoc Oral Maxillofac Surg 39(1):9–13. https://doi.org/10.5125/jkaoms.2013.39.1.9
Article
PubMed
PubMed Central
Google Scholar
Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B, American Association of Oral and Maxillofacial Surgeons (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update. J Oral Maxillofac Surg 67(5 Suppl):2–12. https://doi.org/10.1016/j.joms.2009.01.009
Article
PubMed
Google Scholar
Kuroshima S, Sasaki M, Sawase T (2019) Medication-related osteonecrosis of the jaw: A literature review. J Oral Biosci 61(2):99–104. https://doi.org/10.1016/j.job.2019.03.005
Article
PubMed
Google Scholar
Aljohani S, Fliefel R, Ihbe J, Kuhnisch J, Ehrenfeld M, Otto S (2017) What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review. J Craniomaxillofac Surg 45(9):1493–1502. https://doi.org/10.1016/j.jcms.2017.05.028
Article
PubMed
Google Scholar
Hallmer F, Andersson G, Gotrick B, Warfvinge G, Anderud J, Bjornland T (2018) Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw-a 4-year prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol 126(6):477–485. https://doi.org/10.1016/j.oooo.2018.08.015
Article
PubMed
Google Scholar
Marx RE (2009) Reconstruction of defects caused by bisphosphonate-induced osteonecrosis of the jaws. J Oral Maxillofac Surg 67(5):107–119. https://doi.org/10.1016/j.joms.2008.12.007
Article
PubMed
Google Scholar
Silva LF, Curra C, Munerato MS, Deantoni CC, Matsumoto MA, Cardoso CL, Curi MM (2016) Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review. Oral Maxillofac Surg 20(1):9–17. https://doi.org/10.1007/s10006-015-0538-x
Article
PubMed
Google Scholar
Reich W, Bilkenroth U, Schubert J, Wickenhauser C, Eckert AW (2015) Surgical treatment of bisphosphonate-associated osteonecrosis: Prognostic score and long-term results. J Craniomaxillofac Surg 43(9):1809–1822. https://doi.org/10.1016/j.jcms.2015.07.035
Article
PubMed
Google Scholar